Moleculin Biotech (MBRX) Accumulated Expenses (2016 - 2026)
Moleculin Biotech (MBRX) posted Accumulated Expenses of $4.98 million for Q2 2026, up 18.7% from $4.19 million a year earlier.
Powered by 
Analysis
Moleculin Biotech (MBRX) Accumulated Expenses (2016 - 2026) Analysis & Trends
At the end of FY2025, Moleculin Biotech's Accumulated Expenses came in at $3.35 million, up 0.5% from FY2024.
- Annual Accumulated Expenses shows a five-year compound annual growth rate of 13.3% (FY2020 to FY2025).
- In prior years, Moleculin Biotech's Accumulated Expenses was $3.33 million in FY2024 (-22.9%), $4.32 million in FY2023 (+58.5%), $2.72 million in FY2022 (+20.6%) and $2.26 million in FY2021 (+26.1%).
- The Q2 2026 figure stands as the highest quarterly Accumulated Expenses in data going back to Q4 2016.
- On a year-over-year basis, Accumulated Expenses increased in six of the last seven quarters, with growth averaging 20.9%.
- The strongest year-over-year quarter for Accumulated Expenses in the past five years was Q3 2024, with growth of 61.9%; the weakest was Q3 2023, with a decline of 32.7%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Moleculin Biotech | 2.84 Mn | 2.84 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.98 Mn |
| Dec 31, 2025 | 3.35 Mn |
| Sep 30, 2025 | 3.57 Mn |
| Jun 30, 2025 | 4.19 Mn |
| Mar 31, 2025 | 4.19 Mn |
| Dec 31, 2024 | 3.33 Mn |
| Sep 30, 2024 | 3.04 Mn |
| Jun 30, 2024 | 2.91 Mn |
| Mar 31, 2024 | 3.30 Mn |
| Dec 31, 2023 | 4.32 Mn |
| Sep 30, 2023 | 1.88 Mn |
| Jun 30, 2023 | 2.42 Mn |
| Mar 31, 2023 | 3.09 Mn |
| Dec 31, 2022 | 2.72 Mn |
| Sep 30, 2022 | 2.79 Mn |
| Jun 30, 2022 | 2.68 Mn |
| Mar 31, 2022 | 2.61 Mn |
| Dec 31, 2021 | 2.26 Mn |
| Sep 30, 2021 | 2.27 Mn |
| Jun 30, 2021 | 1.85 Mn |
API Access
Moleculin Biotech Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=MBRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "MBRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=MBRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();